Skip to main content

Advertisement

Log in

Short-term safety of preoperative administration of botulinum toxin A for the treatment of large ventral hernia with loss of domain

  • Original Article
  • Published:
Hernia Aims and scope Submit manuscript

Abstract

Purpose

Preoperative intramuscular-administered botulinum toxin A (BTA) in the lateral abdominal muscles prior to abdominal wall reconstruction has been reported to produce a flaccid paralysis and improve the primary closure rate of large ventral hernias with loss of domain. Complications to this treatment remain sparsely described. The aim of the current study was to report safety and short-term outcome of abdominal wall reconstruction aided by BTA administration.

Methods

This was a retrospective two-center study including all patients undergoing abdominal wall reconstruction for ventral hernia aided by preoperative BTA administration to the lateral abdominal muscles. Data were retrieved from patient charts and included preoperative demographic and perioperative information as well as postoperative 30-day complications and readmissions.

Results

A total of 37 patients underwent BTA administration prior to hernia repair. The mean age and body mass index were 59.5 (SD 10.1) years and 31.1 (SD 5.2) kg/m2. The BTA injections were administered mean 31.6 days (SD 10.0) prior to the hernia repair. One (2.7%) patient reported pain as a complication immediately after the BTA administration. Subsequent to the hernia repair, six (16.2%) patients were readmitted within 30 days. Nine patients (24.3%) had wound complications and medical complications occurred in seven (18.9%) patients.

Conclusions

We found early preoperative administration of BTA a safe adjunct to large ventral hernia repair, without adverse events related to the administration preoperative. Future studies should further highlight the efficacy of preoperative BTA for reconstruction of otherwise untreatable hernias.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jensen KK, Henriksen NA, Jorgensen LN (2014) Endoscopic component separation for ventral hernia causes fewer wound complications compared to open components separation: a systematic review and meta-analysis. Surg Endosc 28(11):3046–3052. https://doi.org/10.1007/s00464-014-3599-2

    Article  PubMed  Google Scholar 

  2. Kokotovic D, Bisgaard T, Helgstrand F (2016) Long-term recurrence and complications associated with elective incisional hernia repair. JAMA 316(15):1575–1582. https://doi.org/10.1001/jama.2016.15217

    Article  PubMed  Google Scholar 

  3. Novitsky YW, Fayezizadeh M, Majumder A, Neupane R, Elliott HL, Orenstein SB (2016) Outcomes of posterior component separation with transversus abdominis muscle release and synthetic mesh sublay reinforcement. Ann Surg 264(2):226–232. https://doi.org/10.1097/SLA.0000000000001673

    Article  PubMed  Google Scholar 

  4. Sabbagh C, Dumont F, Fuks D, Yzet T, Verhaeghe P, Regimbeau JM (2012) Progressive preoperative pneumoperitoneum preparation (the Goni Moreno protocol) prior to large incisional hernia surgery: volumetric, respiratory and clinical impacts. A prospective study. Hernia 16(1):33–40. https://doi.org/10.1007/s10029-011-0849-2

    Article  CAS  PubMed  Google Scholar 

  5. Ibarra-Hurtado TR, Nuno-Guzman CM, Echeagaray-Herrera JE, Robles-Velez E, de Jesus Gonzalez-Jaime J (2009) Use of botulinum toxin type a before abdominal wall hernia reconstruction. World J Surg 33(12):2553–2556. https://doi.org/10.1007/s00268-009-0203-3

    Article  PubMed  Google Scholar 

  6. Ibarra-Hurtado TR, Nuno-Guzman CM, Miranda-Diaz AG, Troyo-Sanroman R, Navarro-Ibarra R, Bravo-Cuellar L (2014) Effect of botulinum toxin type A in lateral abdominal wall muscles thickness and length of patients with midline incisional hernia secondary to open abdomen management. Hernia 18(5):647–652. https://doi.org/10.1007/s10029-014-1280-2

    Article  CAS  PubMed  Google Scholar 

  7. Zendejas B, Khasawneh MA, Srvantstyan B, Jenkins DH, Schiller HJ, Zielinski MD (2013) Outcomes of chemical component paralysis using botulinum toxin for incisional hernia repairs. World J Surg 37(12):2830–2837. https://doi.org/10.1007/s00268-013-2211-6

    Article  PubMed  Google Scholar 

  8. Zielinski MD, Goussous N, Schiller HJ, Jenkins D (2013) Chemical components separation with botulinum toxin A: a novel technique to improve primary fascial closure rates of the open abdomen. Hernia 17(1):101–107. https://doi.org/10.1007/s10029-012-0995-1

    Article  CAS  PubMed  Google Scholar 

  9. Rodriguez-Acevedo O, Elstner KE, Jacombs ASW, Read JW, Martins RT, Arduini F, Wehrhahm M, Craft C, Cosman PH, Dardano AN, Ibrahim N (2018) Preoperative Botulinum toxin A enabling defect closure and laparoscopic repair of complex ventral hernia. Surg Endosc 32(2):831–839. https://doi.org/10.1007/s00464-017-5750-3

    Article  PubMed  Google Scholar 

  10. Farooque F, Jacombs AS, Roussos E, Read JW, Dardano AN, Edye M, Ibrahim N (2016) Preoperative abdominal muscle elongation with botulinum toxin A for complex incisional ventral hernia repair. ANZ J Surg 86(1–2):79–83. https://doi.org/10.1111/ans.13258

    Article  PubMed  Google Scholar 

  11. Jensen KK, Hensler M, Arnesen RB, Jensen K, Jorgensen LN (2017) Patient with a giant umbilical hernia treated preoperatively with botulinum toxin type A [In Danish]. Ugeskrift Laeger 179(4):V09160648

    Google Scholar 

  12. Bueno-Lledo J, Torregrosa A, Ballester N, Carreno O, Carbonell F, Pastor PG, Pamies J, Cortes V, Bonafe S, Iserte J (2017) Preoperative progressive pneumoperitoneum and botulinum toxin type A in patients with large incisional hernia. Hernia 21(2):233–243. https://doi.org/10.1007/s10029-017-1582-2

    Article  CAS  PubMed  Google Scholar 

  13. Haley RW, Culver DH, Morgan WM, White JW, Emori TG, Hooton TM (1985) Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol 121(2):206–215

    Article  CAS  Google Scholar 

  14. Warren JA, Stoddard C, Hunter AL, Horton AJ, Atwood C, Ewing JA, Pusker S, Cancellaro VA, Walker KB, Cobb WS, Carbonell AM, Morgan RR (2017) Effect of multimodal analgesia on opioid use after open ventral hernia repair. J Gastrointest Surg 21(10):1692–1699. https://doi.org/10.1007/s11605-017-3529-4

    Article  PubMed  Google Scholar 

  15. Muse TO, Zwischenberger BA, Miller MT, Borman DA, Davenport DL, Roth JS (2018) Outcomes after ventral hernia repair using the Rives-Stoppa, endoscopic, and open component separation techniques. Am Surg 84(3):433–437

    PubMed  Google Scholar 

  16. Cakmak M, Caglayan F, Somuncu S, Leventoglu A, Ulusoy S, Akman H, Kaya M (2006) Effect of paralysis of the abdominal wall muscles by botulinum A toxin to intraabdominal pressure: an experimental study. J Pediatr Surg 41(4):821–825. https://doi.org/10.1016/j.jpedsurg.2005.12.023

    Article  PubMed  Google Scholar 

  17. Dressler D (2012) Clinical applications of botulinum toxin. Curr Opin Microbiol 15(3):325–336. https://doi.org/10.1016/j.mib.2012.05.012

    Article  PubMed  Google Scholar 

  18. Blatnik JA, Krpata DM, Pesa NL, Will P, Harth KC, Novitsky YW, Rowbottom JR, Rosen MJ (2012) Predicting severe postoperative respiratory complications following abdominal wall reconstruction. Plast Reconstr Surg 130(4):836–841. https://doi.org/10.1097/PRS.0b013e318262f160

    Article  CAS  PubMed  Google Scholar 

  19. Fischer JP, Shang EK, Butler CE, Nelson JA, Braslow BM, Serletti JM, Kovach SJ (2013) Validated model for predicting postoperative respiratory failure: analysis of 1706 abdominal wall reconstructions. Plast Reconstr Surg 132(5):826e–835e. https://doi.org/10.1097/PRS.0b013e3182a4c442

    Article  CAS  PubMed  Google Scholar 

  20. Jensen KK, Backer V, Jorgensen LN (2017) Abdominal wall reconstruction for large incisional hernia restores expiratory lung function. Surgery 161(2):517–524. https://doi.org/10.1016/j.surg.2016.08.015

    Article  PubMed  Google Scholar 

  21. Yang CK, Teng A, Lee DY, Rose K (2015) Pulmonary complications after major abdominal surgery: National Surgical Quality Improvement Program analysis. J Surg Res 198(2):441–449. https://doi.org/10.1016/j.jss.2015.03.028

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Ø. Nielsen.

Ethics declarations

Conflict of interest

MN declares no conflicts of interest. JB declares no conflicts of interest. AD declares no conflicts of interest. LJ declares no conflicts of interest. KJ declares no conflicts of interest.

Ethical approval

No ethical approval was necessary according to Danish law.

Human and animal rights

This article does not contain any studies with human participants requiring further approval due to the retrospective nature.

Informed consent

No informed consent was necessary according to Danish law.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nielsen, M.Ø., Bjerg, J., Dorfelt, A. et al. Short-term safety of preoperative administration of botulinum toxin A for the treatment of large ventral hernia with loss of domain. Hernia 24, 295–299 (2020). https://doi.org/10.1007/s10029-019-01957-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10029-019-01957-1

Keywords

Navigation